Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria

Polymyxin combination therapy is increasingly used clinically. However, systematic investigations of such combinations are a relatively recent phenomenon. The emerging pharmacodynamic (PD) and pharmacokinetic (PK) data on CMS/colistin and polymyxin B suggest that caution is required with monotherapy...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Infect Dis Ther
Asıl Yazarlar: Bergen, Phillip J., Bulman, Zackery P., Landersdorfer, Cornelia B., Smith, Nicholas, Lenhard, Justin R., Bulitta, Jürgen B., Nation, Roger L., Li, Jian, Tsuji, Brian T.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Healthcare 2015
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4675771/
https://ncbi.nlm.nih.gov/pubmed/26645096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-015-0093-7
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller